Node negative breast cancer.
作者信息
Blamey R W, Elston C W, Ellis I O, Morgan D A, Haybittle J L
出版信息
BMJ. 1990 Apr 28;300(6732):1137-8. doi: 10.1136/bmj.300.6732.1137-a.
Abstract
摘要
相似文献
1
Node negative breast cancer.淋巴结阴性乳腺癌
BMJ. 1990 Apr 28;300(6732):1137-8. doi: 10.1136/bmj.300.6732.1137-a.
2
Are axillary lymph nodes still relevant in breast cancer ?腋窝淋巴结在乳腺癌中仍然具有相关性吗？
Ann Surg Oncol. 2014 Dec;21(13):4051-3. doi: 10.1245/s10434-014-3994-x. Epub 2014 Aug 26.
3
[Relation of tumor size, lymph node status and prognosis in breast cancer].[乳腺癌肿瘤大小、淋巴结状态与预后的关系]
Zhonghua Wai Ke Za Zhi. 1991 Sep;29(9):554-7, 589.
4
Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.淋巴结阴性个数增加预示不同淋巴结阳性亚组乳腺癌患者有更好的 OS 和 DSS。
PLoS One. 2018 Mar 19;13(3):e0193784. doi: 10.1371/journal.pone.0193784. eCollection 2018.
5
Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.长期乳腺癌生存与腋窝淋巴结转移瘤负担的关系。
Breast Cancer Res Treat. 2018 Sep;171(2):359-369. doi: 10.1007/s10549-018-4820-0. Epub 2018 May 30.
6
Is axillary dissection needed in node-positive breast cancer?淋巴结阳性乳腺癌患者是否需要进行腋窝淋巴结清扫？
Expert Rev Anticancer Ther. 2008 Feb;8(2):195-8. doi: 10.1586/14737140.8.2.195.
7
Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.Raf/MEK/ERK信号通路与腋窝淋巴结转移乳腺癌患者临床病理特征及预后的相关性
Technol Cancer Res Treat. 2018 Jan 1;17:1533034617754024. doi: 10.1177/1533034617754024.
8
Sentinel lymph-node biopsy in breast cancer.乳腺癌前哨淋巴结活检
Can J Surg. 1999 Dec;42(6):406-7.
9
[-Breast neoplasms: axillary lymph node excision--at what price-].
Arch Gynecol Obstet. 1995;256 Suppl:S85-92.
10
Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.乳腺癌新辅助化疗后腋窝淋巴结清扫中的淋巴结计数及比值：传统pN分期的更佳替代方案
Ann Surg Oncol. 2014 Jan;21(1):42-50. doi: 10.1245/s10434-013-3245-6. Epub 2013 Sep 7.
引用本文的文献
1
Node negative breast cancer.淋巴结阴性乳腺癌
BMJ. 1990 May 26;300(6736):1399-400. doi: 10.1136/bmj.300.6736.1399-c.
本文引用的文献
1
Prognostic significance of the DNA content of human breast cancer.
Br J Surg. 1987 Feb;74(2):133-6. doi: 10.1002/bjs.1800740221.
2
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.原发性和晚期乳腺癌中的雌激素受体：704例病例的八年回顾
Br J Cancer. 1987 Jan;55(1):67-73. doi: 10.1038/bjc.1987.14.
3
Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.乳腺癌中使用单克隆抗体NCRC 11的免疫反应性评估。
Br J Cancer. 1987 Sep;56(3):295-9. doi: 10.1038/bjc.1987.192.
4
Helix pomatia and Ulex europeus lectin binding in human breast carcinoma.欧洲滨螺和荆豆凝集素在人乳腺癌中的结合
J Pathol. 1987 Jul;152(3):169-76. doi: 10.1002/path.1711520305.
5
c-myc oncogene product expression and prognosis in operable breast cancer.可手术乳腺癌中c-myc癌基因产物表达与预后
Br J Cancer. 1989 Nov;60(5):669-72. doi: 10.1038/bjc.1989.337.
6
Node negative breast cancer.淋巴结阴性乳腺癌
BMJ. 1990 Feb 10;300(6721):346-8. doi: 10.1136/bmj.300.6721.346.
Zotero 插件